Dr. Deborah Birx responds to latest study on risks of hydroxycholoquine for COVID-19

2513 Imported from a malfunctioning feed
edited May 22 in US Political Debate
White House coronavirus coordinator Dr. Deborah Birx was asked Friday about results of a new study showing COVID-19 patients got no benefit and suffered some serious side effects from the malaria drug President Trump has pushed as a possible treatment. She noted that many of those patients had other health issues. Watch her remarks.
Sign In or Register to comment.

About Cookies

We use cookies so you can stay logged in, we do not collect information for advertising or any other reason. Please Accept.

Sport Forum